Guy Schwartz

Research activity per year

Fingerprint

Dive into the research topics where Guy Schwartz is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

7 Active
8 Finished

WEP Clinical: Emalex Biosciences, Inc - EBS-101-TD-392, An Open Label Expanded Access Program Intended to Provide Treatment with Ecopipam (EBS-101) to Children, Adolescents and Adults in the U.S. with Tourette's Disorder
Maurer, C. (PI) & Schwartz, G. (CoPI)
Emalex Biosciences Incorporated
05/8/26 → 11/14/26
Stony Brook University
Project: Research
2026: Level 3: Huntington's Disease Society of America Center of Excellence
Schwartz, G. (PI), Muratori, L. M. (CoPI), Harabes, E. (CoI) & Stern, R. (CoI)
01/1/26 → …
Stony Brook University
Project: Research
Emalex Biosciences: A Multicenter, Open-Label, Study to Evaluate the Longterm Safety of Ecopipam Tablets in Children, Adolescents and Adults with Tourette's Disorder
Maurer, C. (PI) & Schwartz, G. (CoPI)
Syneos Health LLC
09/2/25 → 09/1/26
Stony Brook University
Project: Research
A Double-Blind, Placebo-Controlled, Phase IIb, Multi-center, Twelve-week Prospective Study to Evaluate the Efficacy and Safety of Gemlapodect in Adult and Adolescent Patients with Tourette Syndrome
Maurer, C. (PI) & Schwartz, G. (CoPI)
Noema Pharma
06/25/25 → 06/30/27
Stony Brook University
Project: Research
2025 Huntington's Disease Society of America Center of Excellence
Schwartz, G. (PI), Muratori, L. M. (CoI), Harabes, E. (CoI) & Stern, R. (CoI)
02/1/25 → …
Stony Brook University
Project: Research

4 Article
1 Editorial
1 Review article

Long-standing overt ventriculomegaly in adults (LOVA) as a distinct entity on the neurologist's differential: A narrative review
Mani, R., Basem, J., Schwartz, G. & Egnor, M., May 1 2025, In: BMJ Neurology Open. 7, 1, e001021.
Stony Brook University
Research output: Contribution to journal › Review article › peer-review

Open Access
2 Scopus citations
Parkinson's Disease With Visual Hallucinations Is Associated With Epileptiform Activity on EEG
Fry, A., Singh, D., Manganas, L., Gordon, M. L., Christodoulou, C., Leung, H. C. & Schwartz, G. J., Jan 11 2022, In: Frontiers in Neurology. 12, 788632.
Stony Brook University
Research output: Contribution to journal › Article › peer-review

Open Access
4 Scopus citations
Safety and tolerability of srx246, a vasopressin 1a antagonist, in irritable huntington’s disease patients—a randomized phase 2 clinical trial
Brownstein, M. J., Simon, N. G., Long, J. D., Yankey, J., Maibach, H. T., Cudkowicz, M., Coffey, C., Conwit, R. A., Lungu, C., Anderson, K. E., Hersch, S. M., Ecklund, D. J., Damiano, E. M., Itzkowitz, D. E., Lu, S., Chase, M. K., Shefner, J. M., McGarry, A., Thornell, B. & Gladden, C. & 46 others, Costigan, M., O’suilleabhain, P., Marshall, F. J., Chesire, A. M., Deritis, P., Adams, J. L., Hedera, P., Lowen, K., Diana Rosas, H., Hiller, A. L., Quinn, J., Keith, K., Duker, A. P., Gruenwald, C., Molloy, A., Jacob, C., Factor, S., Sperin, E., Bega, D., Brown, Z. R., Seeberger, L. C., Sung, V. W., Benge, M., Kostyk, S. K., Daley, A. M., Perlman, S., Suski, V., Conlon, P., Barrett, M. J., Lowenhaupt, S., Quigg, M., Perlmutter, J. S., Wright, B. A., Most, E., Schwartz, G. J., Lamb, J., Chuang, R. S., Singer, C., Marder, K., Moran, J. A., Singleton, J. R., Zorn, M., Wall, P. V., Dubinsky, R. M., Gray, C. & Drazinic, C., Nov 2020, In: Journal of Clinical Medicine. 9, 11, 3682.
Stony Brook University
Research output: Contribution to journal › Article › peer-review

Open Access
28 Scopus citations
Levodopa improves response inhibition and enhances striatal activation in early-stage Parkinson's disease
Manza, P., Schwartz, G., Masson, M., Kann, S., Volkow, N. D., Li, C. S. R. & Leung, H. C., Jun 2018, In: Neurobiology of Aging. 66, p. 12-22 11 p.
Stony Brook University
Research output: Contribution to journal › Article › peer-review

Open Access
32 Scopus citations
Bitemporal electroconvulsive therapy for depression in a parkinson disease patient with a deep-brain stimulator
Bailine, S., Kremen, N., Kohen, I., Linder, H., Schwartz, G. J., Mogilner, A. Y. & Pourfar, M., Jun 2008, In: Journal of ECT. 24, 2, p. 171-172 2 p.
Stony Brook University
Research output: Contribution to journal › Article › peer-review
39 Scopus citations

Guy Schwartz

Fingerprint

Collaborations and top research areas from the last five years

Dive into details

WEP Clinical: Emalex Biosciences, Inc - EBS-101-TD-392, An Open Label Expanded Access Program Intended to Provide Treatment with Ecopipam (EBS-101) to Children, Adolescents and Adults in the U.S. with Tourette's Disorder

2026: Level 3: Huntington's Disease Society of America Center of Excellence

Emalex Biosciences: A Multicenter, Open-Label, Study to Evaluate the Longterm Safety of Ecopipam Tablets in Children, Adolescents and Adults with Tourette's Disorder

A Double-Blind, Placebo-Controlled, Phase IIb, Multi-center, Twelve-week Prospective Study to Evaluate the Efficacy and Safety of Gemlapodect in Adult and Adolescent Patients with Tourette Syndrome

2025 Huntington's Disease Society of America Center of Excellence

Long-standing overt ventriculomegaly in adults (LOVA) as a distinct entity on the neurologist's differential: A narrative review

Parkinson's Disease With Visual Hallucinations Is Associated With Epileptiform Activity on EEG

Safety and tolerability of srx246, a vasopressin 1a antagonist, in irritable huntington’s disease patients—a randomized phase 2 clinical trial

Levodopa improves response inhibition and enhances striatal activation in early-stage Parkinson's disease

Bitemporal electroconvulsive therapy for depression in a parkinson disease patient with a deep-brain stimulator

Guy Schwartz

Fingerprint

Collaborations and top research areas from the last five years

Grants & Projects

Research output